The CRUK Convergence Science Centre is led by its Executive Management Committee and has Subcommittees responsible for Research and Training (clinical and non-clinical). Oversight is provided by an independently chaired Governance Board comprising senior management representatives from Cancer Research UK and the Centre partner organisations.  

The Governance Board receives scientific advice from a Scientific Advisory Board comprised of international experts in cancer science and technology.  

The Centre is administered by an Operational team that sits between Imperial College London and The Institute of Cancer Research, London.  

The Centre is also recognised as a Centre of Excellence within Imperial and as a research division within the ICR. 

The Cancer Research UK Convergence Science Centre is a partnership between The Institute of Cancer Research (ICR) and Imperial College London with funding from Cancer Research UK.   

We are a Centre of Excellence within Imperial College London. 

We closely collaborate with partner NHS trusts, The Royal Marsden NHS Foundation Trust and Imperial College Healthcare NHS Trust as well as with local NIHR Biomedical Research Centres, centres and networks of excellence across our partner institutions and clinical units 

Find out more about each of our partners below.  

• Cancer Research UK: the world’s largest independent charity dedicated to saving lives through research. Cancer Research UK is the world’s largest independent charity dedicated to saving lives through research.
• Imperial College London: a science-based university with an international reputation for excellence in teaching and research
• Imperial College London NHS Trust: Formed in 2007, provides acute and specialist healthcare in north west London for around a million people every year.
• Institute of Cancer Research: one of the world’s most influential cancer research organisations, with a mission to make the discoveries that defeat cancer.
• Royal Marsden Hospital NHS Foundation Trust: opened its doors in 1851 as the world’s first hospital dedicated to cancer diagnosis, treatment, research and education. With the ICR, is the only National Institute for Health Research Biomedical Research Centre for Cancer, supporting pioneering research work carried out over a number of different cancer themes.

Thanks to the leadership and vision of Professors Workman and Darzi, the Cancer Research Centre of Excellence was awarded as a CRUK Major Centre.  

In 2020, Professor Axel Behrens joined the Centre as its inaugural Scientific Director with joint appointment between the Imperial College London and The Institute of Cancer Research. 

In 2022, the CRUK Imperial Centre, CRUK ICR Centre and the Convergence Science Centre merged, giving rise to the renewed and unified CRUK Convergence Science Centre.  

Our mission remains to accelerate the development of ground-breaking cancer technologies across our partnering institutions.